Gennex Laboratories to raise funds through permissible modes

29 Mar 2022 Evaluate

Gennex Laboratories is planning to raise funds by issuance of equity shares or any other securities, through permissible modes including but not limited to a rights issue, as may be permitted under applicable law and subject to such regulatory/ statutory approvals, as may be required. A meeting of Board of Directors of the Company will be held on April 06, 2022 to consider the same.

Gennex Laboratories is engaged in the manufacture and export of bulk drugs and intermediates. The product range of the company includes Guaiphenesin,Methocarbamol,Fluconazole and Phenazopyridine. 

Gennex Lab Share Price

17.15 -0.33 (-1.89%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.